These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37792394)

  • 41. Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial.
    Leweke FM; Rohleder C; Gerth CW; Hellmich M; Pukrop R; Koethe D
    Front Pharmacol; 2021; 12():614811. PubMed ID: 33995015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Source of cannabinoids: what is available, what is used, and where does it come from?
    Specchio N; Pietrafusa N; Cross HJ
    Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cannabidiol (CBD) use in psychiatric disorders: A systematic review.
    Bonaccorso S; Ricciardi A; Zangani C; Chiappini S; Schifano F
    Neurotoxicology; 2019 Sep; 74():282-298. PubMed ID: 31412258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.
    Black N; Stockings E; Campbell G; Tran LT; Zagic D; Hall WD; Farrell M; Degenhardt L
    Lancet Psychiatry; 2019 Dec; 6(12):995-1010. PubMed ID: 31672337
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabinoids and the Microbiota-Gut-Brain Axis: Emerging Effects of Cannabidiol and Potential Applications to Alcohol Use Disorders.
    Karoly HC; Mueller RL; Bidwell LC; Hutchison KE
    Alcohol Clin Exp Res; 2020 Feb; 44(2):340-353. PubMed ID: 31803950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior.
    Ganesh S; Cortes-Briones J; Schnakenberg Martin AM; Skosnik PD; D'Souza DC; Ranganathan M
    Cannabis Cannabinoid Res; 2023 Oct; 8(5):846-856. PubMed ID: 35319274
    [No Abstract]   [Full Text] [Related]  

  • 48. Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studies.
    Daldegan-Bueno D; Maia LO; Glass M; Jutras-Aswad D; Fischer B
    Eur Neuropsychopharmacol; 2021 Oct; 51():106-131. PubMed ID: 34273801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
    Hindocha C; Freeman TP; Schafer G; Gardener C; Das RK; Morgan CJ; Curran HV
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):325-34. PubMed ID: 25534187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals.
    Galaj E; Xi ZX
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum Markers of Bone Turnover Following Controlled Administration of Two Medical Cannabis Products in Healthy Adults.
    Kulpa J; Eglit G; Hill ML; MacNair L; Yardley H; Ware MA; Bonn-Miller MO; Peters EN
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):300-309. PubMed ID: 36346322
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers.
    Woelfl T; Rohleder C; Mueller JK; Lange B; Reuter A; Schmidt AM; Koethe D; Hellmich M; Leweke FM
    Front Psychiatry; 2020; 11():576877. PubMed ID: 33304282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Systematic Review of Medical Cannabinoids Dosing in Human.
    Campos DA; Mendivil EJ; Romano M; García M; Martínez ME
    Clin Ther; 2022 Dec; 44(12):e39-e58. PubMed ID: 36411116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cannabinoid Exposure and Subjective Effects of THC and CBD in Edible Cannabis Products.
    Gibson LP; Mueller RL; Winiger EA; Klawitter J; Sempio C; Williams S; Bryan AD; Bidwell LC; Hutchison KE
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):320-334. PubMed ID: 36378267
    [No Abstract]   [Full Text] [Related]  

  • 55. Cannabidiol for Oral Health: A New Promising Therapeutical Tool in Dentistry.
    Bellocchio L; Patano A; Inchingolo AD; Inchingolo F; Dipalma G; Isacco CG; de Ruvo E; Rapone B; Mancini A; Lorusso F; Scarano A; Malcangi G; Inchingolo AM
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cannabidiol Adverse Effects and Toxicity.
    Huestis MA; Solimini R; Pichini S; Pacifici R; Carlier J; Busardò FP
    Curr Neuropharmacol; 2019; 17(10):974-989. PubMed ID: 31161980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of cannabidiol in anxiety and anxiety-related disorders.
    Skelley JW; Deas CM; Curren Z; Ennis J
    J Am Pharm Assoc (2003); 2020; 60(1):253-261. PubMed ID: 31866386
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment.
    Lawn W; Trinci K; Mokrysz C; Borissova A; Ofori S; Petrilli K; Bloomfield M; Haniff ZR; Hall D; Fernandez-Vinson N; Wang S; Englund A; Chesney E; Wall MB; Freeman TP; Curran HV
    Addiction; 2023 Jul; 118(7):1282-1294. PubMed ID: 36750134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats.
    Gabaglio M; Zamberletti E; Manenti C; Parolaro D; Rubino T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study.
    Chester LA; Englund A; Chesney E; Oliver D; Wilson J; Sovi S; Dickens AM; Oresic M; Linderman T; Hodsoll J; Minichino A; Strang J; Murray RM; Freeman TP; McGuire P
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):188-198. PubMed ID: 36493386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.